Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection

Journal of Hepatology

Volumn 29, Issue 1, 1998, Pages 45-52

  Puoti, Massimo ^a,c   Rossi, Stefania ^a   Forleo, Maria Antonia ^a   Zaltron, Serena ^a   Spinetti, Angiola ^a   Putzolu, Valeria ^a   Rodella, Anna ^b   Carosi, Giampiero ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b General Hospital of Brescia   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

HBV; HCV; HDV; Hepatitis; HIV; Interferon

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032125421     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80177-3     Document Type: Article

References (28)

1. Novick DM, Khan I, Kreek MJ. Acquired immunodeficiency syndrome and infection with hepatitis viruses in individuals abusing drugs by injection. Bull Narc. 38:1986;15-25.
2. Kreek MJ, Des Jarlais DC, Trepo CL, Novick DM, Abdul Quader A, Raghunath J. Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS. J Infect Dis. 162:1990;538-541.
3. Purcell RH, Rizzetto M, Gerin JL. Hepatitis delta virus infection of the liver. Semin Liver Dis. 4:1984;340-346.
4. Novick DM, Farci P, Croxson TS, Taylor MB, Schneebaum CW, Lai ME, et al. Hepatitis D virus and human immuno-deficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis. 158:1988;795-803.
5. Housset C, Pol S, Carnot F, Dubois F, Nalpas B, Housset B, et al. Interactions between human immunodeficiency virus 1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology. 15:1992;578-583.
6. Porres JC, Carreno V, Bartolomé J, Moreno A, Galiana F, Quiroga JA. Treatment of chronic delta infection with recombinant human IFN alpha 2c at high doses. J Hepatol. 9:1989;338-344.
7. Di Bisceglie AM, Martin P, Lisker-Melman M, Kassianides C, Korenman J, Bergasa NV, et al. Therapy of chronic delta hepatitis with IFN alpha-2b. J Hepatol. 11:1990;151-154. (Suppl 1).
8. Buti M, Esteban R, Roget M, Jardi R, Esteban JI, Casacuberta JM, et al. Long-term treatment with IFN alpha-2b in patients with chronic delta hepatitis and HIV antibodies. J Hepatol. 11:1990;174. (Suppl 1).
9. Hadziyannis SJ. Use of α-IFN in the treatment of chronic delta hepatitis. J Hepatol. 13:1991;21-26. (Suppl 1).
10. Rosina F, Pintus C, Meschievitz C, Rizzetto M. A randomized controlled trial of a 12-month course of recombinant human IFN-α in chronic delta (type D) hepatitis: a multicentric Italian study. Hepatology. 13:1991;1052-1056.
11. 2a: utility of polymerase chain reaction in monitoring antiviral response. Hepatology. 19:1994;1331-1336.
12. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, et al. Treatment of chronic hepatitis D with IFN alpha-2a. N Engl J Med. 330:1994;88-94.
13. Gaudin J-L, Faure P, Godinot H, Gerard F, Trepo C. The French experience of treatment of chronic type D hepatitis with a 12-month course of IFN alpha-2B. Results of a randomized controlled trial. Liver. 15:1995;45-52.
14. Taillan B, Fuzibet JG, Vinti H, Pesce A, Cassuto JP, Dujardin P. IFN and delta hepatitis [letter]. Ann Intern Med. 111:1988;160.
15. AIDS operative centre. Istituto Superiore di Sanità: Guidelines for Zidovudine use. ISS. 1989.
16. Knodell RG, Ishak KM, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
17. Cariani E, Ravaggi A, Puoti M, Mantero G, Albertini A, Primi D. Evaluation of hepatitis delta virus RNA levels during IFN therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay. Hepatology. 15:1992;685-689.
18. Bonino F, Negro F, Baldi M. The natural history of chronic delta hepatitis. Rizzetto M, Gerin JL, Purcell RH. The Hepatitis Delta Virus and its Infection. 1987;145-152 Alan R. Liss, New York.
19. Buti M, Jardi R, Allende H, Cotrina M, Rodriguez F, Villadomiu L, et al. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus? J Med Virol. 49:1996;66-69.
20. Soriano V, Garcia-Samaniego J, Bravo R, Gutierrez M, Gonzalez-Lahoz J. High morbidity and mortality with chronic viral liver disease in HIV-infected individuals in Spain. J Infect. 28:1994;100-101.
21. Eyster ME, Sanders JC, Battegay M, Di Bisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci. 40:1995;1583-1588.
22. + cells after IFNα treatment in HIV-1 infection [letter]. Lancet. 341:1993;1597.
23. + T-lymphocytopenia in HIV-infected patients ongoing IFN therapy for chronic hepatitis C. AIDS. 8:1994;1621-1622.
24. Pesce A, Taillan B, Rosenthal E, Garnier G, Vinti H, Dujardi P, et al. Opportunistic infections and CD4 lymphocytopenia with IFN treatment in HIV-1 infected patients [letter]. Lancet. 341:1993;1597.
25. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 105:1993;1529-1533.
26. Ottobrelli A, Marzano A, Smedile A, Recchia S, Salizzoni M, Cornu C, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology. 101:1991;1649-1655.
27. Samuel D, Zignego AL, Reynes M, Feray C, Arulmadem JL, David MF, et al. Long term clinical and virological outcome after live transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology. 21:1995;333-339.
28. Miles SA. Long term therapeutic strategies in HIV. J AIDS. 16:1997;36-41. (Suppl 1).